老年人药疗中的隐秘危险:多药,多病症和药物相互作用的相互作用
1Discipline of Pharmaceutical Sciences, School of Health Sciences, University of KwaZulu-Natal, Durban, South Africa.
Journal of evaluation in clinical practice
|September 30, 2025
概括
药物相互作用是老年人由于生理变化和多种药物的重大可预防风险. 通过合作优化药物治疗是提高患者安全和结果的关键.
科学领域:
- 老年人药理学 老年人药理学
- 临床药房 临床药房
- 患者安全 患者安全
背景情况:
- 老年人的药物治疗因与年龄相关的生理变化,多病症和多药性而复杂化.
- 这些因素增加了老年患者药物相互作用和药物不良反应的风险.
研究的目的:
- 审查老年人药物相互作用的机制,原因和后果.
- 在老年人群中确定优化药物治疗的策略.
主要方法:
- 对现有文献进行了叙事审查.
- 审查的重点是关于老年患者与年龄相关的药理变化,多病症,多药学和药物相互作用的研究.
主要成果:
- 药物相互作用是老年人药物治疗中最容易预防的医疗错误之一.
- 这个问题的广泛性要求医疗保健专业人员提高意识和共同努力.
结论:
- 提高老年人药物治疗质量需要集中精力预防药物相互作用和优化处方.
- 协作干预对于减少药物不良事件和改善老年护理治疗结果至关重要.
相关概念视频
Drug Dosing: Geriatric Patients
199
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
199
Pharmacodynamics in Geriatric Patients: Effects of Age
172
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
172
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
176
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
176
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
201
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
201
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
200
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
200
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
214
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
214


